JPH0479358B2 - - Google Patents

Info

Publication number
JPH0479358B2
JPH0479358B2 JP58248519A JP24851983A JPH0479358B2 JP H0479358 B2 JPH0479358 B2 JP H0479358B2 JP 58248519 A JP58248519 A JP 58248519A JP 24851983 A JP24851983 A JP 24851983A JP H0479358 B2 JPH0479358 B2 JP H0479358B2
Authority
JP
Japan
Prior art keywords
active substance
physiologically active
present
activity
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58248519A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60139624A (ja
Inventor
Junji Kuwajima
Hiroshi Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Kogyo KK filed Critical Asahi Kasei Kogyo KK
Priority to JP58248519A priority Critical patent/JPS60139624A/ja
Publication of JPS60139624A publication Critical patent/JPS60139624A/ja
Publication of JPH0479358B2 publication Critical patent/JPH0479358B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP58248519A 1983-12-27 1983-12-27 抗腫瘍作用を有する蛋白質 Granted JPS60139624A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58248519A JPS60139624A (ja) 1983-12-27 1983-12-27 抗腫瘍作用を有する蛋白質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58248519A JPS60139624A (ja) 1983-12-27 1983-12-27 抗腫瘍作用を有する蛋白質

Publications (2)

Publication Number Publication Date
JPS60139624A JPS60139624A (ja) 1985-07-24
JPH0479358B2 true JPH0479358B2 (enExample) 1992-12-15

Family

ID=17179390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58248519A Granted JPS60139624A (ja) 1983-12-27 1983-12-27 抗腫瘍作用を有する蛋白質

Country Status (1)

Country Link
JP (1) JPS60139624A (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0695939B2 (ja) * 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
JPS60137292A (ja) * 1983-12-26 1985-07-20 Asahi Chem Ind Co Ltd 新規生理活性ポリペプチドの遺伝情報を有するポリデオキシリボ核酸、該ポリデオキシリボ核酸を含む複製可能な組換ｄνａ、該複製可能な組換ｄνａで形質転換された微生物または細胞、新規生理活性ポリペプチド及びその製造方法
JPH0443080A (ja) * 1990-06-08 1992-02-13 Konica Corp 感熱記録体

Also Published As

Publication number Publication date
JPS60139624A (ja) 1985-07-24

Similar Documents

Publication Publication Date Title
Erlanson et al. Purification and characterization of two proteins with co-lipase activity from porcine pancreas
US3948875A (en) Process for the preparation of epidermal growth factor and new derivative using cross-linked polyacrylamide gel at a pH of 1-3
US3945889A (en) Preparation of human placental hyaluronidase
EP0090892B1 (en) Process for the purification of physiologically active substance having antitumour activity
US4529594A (en) Protein having antitumor activity
CN1064050C (zh) 生物抗菌肽及其制备方法
US4845078A (en) Method for treating hematopoietic diseases
US5097019A (en) Pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4
US4920196A (en) Human lymphotoxin
JPH0229317B2 (enExample)
KR920009523B1 (ko) 토끼암괴사인자를 코우드하는 dna 및 토기암괴사인자 폴리 펩티드의 제조방법
EP0301374B1 (de) Verfahren zur Reinigung des plazentaren Gewebeproteins PP4
Ole-MoiYoi et al. Structural studies of human urinary kallikrein (urokallikrein).
Takahashi et al. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom
US5723325A (en) Indolyl-3-alkane alpha-hydroxylase compositions from pseudomonas XA
JPS6363559B2 (enExample)
US20090093038A1 (en) Method for the production of pure virally inactivated butyrylcholinesterase
JPS6019720A (ja) ヒト内来性癌制御因子およびその製造法
JPS60139624A (ja) 抗腫瘍作用を有する蛋白質
US5023320A (en) Process for the purification of physiologically active substance having antitumor activity
EP0232384A1 (en) Isolation of an endotoxin inactivator from human plasma
JPS60243018A (ja) ヒト内来性癌制御因子
Murooka et al. Affinity chromatography of Klebsiella arylsulfatase on tyrosyl-hexamethylenediamino-β-1, 3-glucan and immunoadsorbent
JPH0427998B2 (enExample)
Spragg et al. Structural studies of human urinary kallikrein (urokallikrein)